Aytu Biopharma (AYTU) Net Margin Growth (1y) (2014 - 2025)

Aytu Biopharma (AYTU) Net Margin Growth (1y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 364.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -82.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,395.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -538.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9,850.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,292.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -146.00
10 Aytu Biopharma 1.43 Mn -25.28 Mn 7.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 890.00
Mar 31, 2025 456.00
Dec 31, 2024 523.00
Sep 30, 2024 593.00
Jun 30, 2024 -50.00
Mar 31, 2024 2,740.00
Dec 31, 2023 2,099.00
Sep 30, 2023 -110.00
Jun 30, 2023 -3,335.00
Mar 31, 2023 18,855.00
Dec 31, 2022 2,447.00
Sep 30, 2022 12,466.00
Jun 30, 2022 10,516.00
Dec 31, 2021 1,295.00
Sep 30, 2021 -9,534.00
Jun 30, 2021 -3,080.00
Dec 31, 2020 10,764.00
Sep 30, 2020 31,061.00
Jun 30, 2020 21,794.00
Mar 31, 2020 12,359.00